Clin2
NCT06475430Possibly a fitNot yet recruiting

Fecal transplant for bowel problems after rectal cancer surgery

Low Anterior Resection SyndromeFecal Microbiota Transplantation

Treatments studied

Part of Digestive system clinical trials.

This trial tests whether transferring healthy bacteria from a donor's stool (called fecal microbiota transplantation) can improve bowel problems like frequent bowel movements or trouble controlling gas or stool, which are common after rectal cancer surgery. The goal is to see if this treatment helps you feel better and improves your quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You had surgery for rectal cancer (called total mesorectal excision) that removed the tumor but kept your anus, and it's been more than 3 months since that surgery.
  • You have moderate to severe bowel problems after surgery, like frequent bowel movements, urgency, or difficulty controlling gas or stool (measured by a score between 21 and 42).
  • You are generally well enough to carry out daily activities (performance status 0 or 1).
  • You have not had radiation therapy to the pelvic area, and you don't currently have a colostomy bag.
  • You haven't taken antibiotics, probiotics, or prebiotics in the last 4 weeks, and you aren't pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04706611Recruiting
Stool transplant to treat gut and immune-related conditions

This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.

Guangzhou, Guangdong
NCT03804931Recruiting· Phase 2/Phase 3
Stool transplant for moderate to severe ulcerative colitis

This trial tests whether transplanting stool bacteria into the colon (fecal microbiota transplantation) can improve ulcerative colitis symptoms in people with active, moderate to severe disease. If you qualify, the study team will also check that it’s safe for you and that you can safely undergo a scope exam.

Guangzhou, Guangdong
NCT07154784Enrolling by invitation· Phase 2/Phase 3
Fecal transplant for long-term ulcerative colitis treatment

This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.

Seoul, Dongjak-gu
NCT06776029Recruiting· Phase 2
Fecal transplant for radiation-induced rectal bleeding

This study tests whether a fecal (stool) transplant can help heal rectal damage caused by pelvic radiation. The treatment may decrease bleeding and improve symptoms for people whose supportive care hasn't worked well.

Guangzhou, Guangdong
NCT05776914Recruiting· Phase 2
Fecal transplant to treat moderate to severe IBS symptoms

This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.

Rochester, Minnesota
NCT07369830Recruiting
Probiotics for bowel function after rectal cancer surgery

This trial tests whether taking a probiotic supplement (Clostridium butyricum) can improve gut health and bowel function after surgery for very low rectal cancer. It may help patients who have a temporary ileostomy and are planning to have it reversed within 6 months.

Shanghai, Shanghai Municipality

Hear when a new Low Anterior Resection Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.